Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genotypic Resistance-guided vs Empirical Concomitant Therapy for H. Pylori
NCT04090021Phase 4Unknown
- Sponsor
- Konstantopoulio General Hospital
- Start
- Sep 2019
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of esomeprazole, amoxicillin, clarithromycin, levofloxacin, rifabutin in Helicobacter pylori infection, sponsored by Konstantopoulio General Hospital. Status: unknown.
02
Drugs
esomeprazoleamoxicillinclarithromycinlevofloxacinrifabutin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT04090021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04090021.